Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI, United States.
Department of Medicine, Bone Marrow Transplant Program, Medical College of Wisconsin, Milwaukee, WI, United States.
Front Immunol. 2019 Feb 22;10:163. doi: 10.3389/fimmu.2019.00163. eCollection 2019.
Graft vs. host disease (GVHD) is the major non-relapse complication associated with allogeneic hematopoietic stem cell transplantation (HSCT). Damage to the gastrointestinal (GI) tract from acute GVHD is a particularly serious event that can result in significant morbidity and mortality. Proinflammatory cytokines play a critical role in the pathophysiology of intestinal GVHD, in part by activating donor T cell populations which subsequently induce tissue damage. In this review, we summarize pre-clinical data derived from experimental murine models that have examined the role of inflammatory cytokine pathways that play critical roles in the pathophysiology of GVHD of the GI tract. Specific areas of focus are on STAT 3-dependent cytokines (e.g., IL-6, IL-23, and IL-21), and members of the IL-1 cytokine family, both of which have been shown to induce pathological damage within the GI tract during this disease. We also review established and ongoing efforts to translate these pre-clinical findings into the clinic in an effort to reduce morbidity and mortality due to this complication.
移植物抗宿主病(GVHD)是与异基因造血干细胞移植(HSCT)相关的主要非复发并发症。急性 GVHD 对胃肠道(GI)的损害是一个特别严重的事件,可导致显著的发病率和死亡率。促炎细胞因子在肠道 GVHD 的病理生理学中起着关键作用,部分原因是通过激活供体 T 细胞群,随后诱导组织损伤。在这篇综述中,我们总结了来源于实验性小鼠模型的临床前数据,这些数据研究了在胃肠道 GVHD 的病理生理学中起关键作用的炎症细胞因子途径的作用。重点关注的领域是 STAT3 依赖性细胞因子(例如,IL-6、IL-23 和 IL-21)和 IL-1 细胞因子家族的成员,在这种疾病中,这两者都被证明会在胃肠道内引起病理性损伤。我们还回顾了将这些临床前发现转化为临床实践的既定和正在进行的努力,以降低这种并发症的发病率和死亡率。